Metropolis Healthcare Reports Flat Q3 FY24-25 Results Amid Mixed Financial Indicators

Metropolis Healthcare has recently reported its financial results for the quarter ending December 2024, revealing a flat performance for Q3 FY24-25. The company's evaluation has undergone a notable adjustment, with its score reflecting a decline over the past three months.
In terms of positive indicators, Metropolis Healthcare has achieved a commendable debt-equity ratio of 0.16 times, marking the lowest level in the last five half-year periods. This trend suggests a consistent reduction in borrowing relative to equity capital. Additionally, the company has demonstrated efficiency in managing its receivables, as evidenced by a debtor turnover ratio of 9.58 times, the highest recorded in the same timeframe.

Conversely, the financial results also highlight challenges for Metropolis Healthcare. The profit before tax (PBT) has shown a decline, recorded at Rs 39.78 crore, which is a decrease compared to the average PBT of the previous four quarters. Similarly, the profit after tax (PAT) stands at Rs 31.36 crore, also reflecting a downward trend. Furthermore, the company's cash and cash equivalents have reached their lowest point in the last six half-year periods, indicating a deterioration in short-term liquidity.

For more insights on Metropolis Healthcare's performance and evaluation changes, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.